Published: 2015-02-25
Proceedings
The Evolving Landscape of GI Tumors
Abstract 72 | PDF Downloads 33Page 3
HER-2 and Gastric Cancer
Abstract 59 | PDF Downloads 34Page 5-7
Circulating tumor cells: current challenges and future perspectives
Abstract 69 | PDF Downloads 35Page 11-13
Update in localized rectal cancer
Abstract 48 | PDF Downloads 32Page 14-17
Therapeutic algorithm of pancreatic neuroendocrine neoplasms
Abstract 86 | PDF (Italian) Downloads 34Page 18-20
Neoadjuvant therapy of gastroesophageal junction adenocarcinoma: chemoradiotherapy or chemotherapy
Abstract 84 | PDF Downloads 32Page 21-23
Gastric Cancer: therapeutic choices in advanced disease
Abstract 57 | PDF Downloads 36Page 24-25
S-1 in the treatment of advanced gastric cancer: up-date
Abstract 108 | PDF Downloads 38Page 26-29
Ramucirumab: a new option in advanced gastric cancer
Abstract 62 | PDF Downloads 31Page 30-32
Bevacizumab beyond progression: Pros
Abstract 52 | PDF Downloads 38Page 33-35
The Challenge of anti-EGFR therapy-rechallenge in management of metastatic colorectal cancer
Abstract 98 | PDF Downloads 42Page 36-39
Second line treatment of metastatic colorectal cancer: aflibercept
Abstract 194 |Page 40-44
Resistance to biologic drugs
Abstract 65 | PDF Downloads 33Page 45-46
Monotherapy vs doublet chemotherapy vs Folfirinox: who and why
Abstract 62 | PDF Downloads 36Page 47-49
SPARC and treatment in pancreatic ductal adenocarcinoma: evidences and new challenge for the future
Abstract 87 | PDF Downloads 38Page 50-51
Update on nab-Paclitaxel in the treatment of pancreatic cancer
Abstract 73 | PDF Downloads 39Page 52-54